{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:18:01Z","timestamp":1754151481688,"version":"3.41.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"DOI":"10.7759\/cureus.88269","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T03:54:35Z","timestamp":1752897275000},"source":"Crossref","is-referenced-by-count":0,"title":["Isolated Myositis Unveiling Systemic Lupus Erythematosus: A Rare Initial Presentation"],"prefix":"10.7759","author":[{"given":"Amit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarti","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhvika","family":"Zutshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos GC","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011, 365:2110-21. 10.1056\/NEJMra1100359","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn BH","year":"2012","unstructured":"Hahn BH, McMahon MA, Wilkinson A, et al.. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012, 64:797-808. 10.1002\/acr.21664","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"41","author":"Sultan SM","year":"2002","unstructured":"Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford). 2002, 41:22-6. 10.1093\/rheumatology\/41.1.22","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.10.1067","article-title":"Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases","volume":"36","author":"Garton MJ","year":"1997","unstructured":"Garton MJ, Isenberg DA. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases. Br J Rheumatol. 1997, 36:1067-74. 10.1093\/rheumatology\/36.10.1067","journal-title":"Br J Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas MC","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015, 372:1734-47. 10.1056\/NEJMra1402225","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri M","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al.. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2677-86.","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.09.009","article-title":"EULAR\/ACR classification criteria for SLE","volume":"49","author":"Aringer M","year":"2019","unstructured":"Aringer M. EULAR\/ACR classification criteria for SLE. Semin Arthritis Rheum. 2019, 49:S14-7. 10.1016\/j.semarthrit.2019.09.009","journal-title":"Semin Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2013.06.001","article-title":"Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies","volume":"39","author":"Rider LG","year":"2013","unstructured":"Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2013, 39:877-904. 10.1016\/j.rdc.2013.06.001","journal-title":"Rheum Dis Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.3.178","article-title":"Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters","volume":"53","author":"Lim KL","year":"1994","unstructured":"Lim KL, Abdul-Wahab R, Lowe J, Powell RJ. Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters. Ann Rheum Dis. 1994, 53:178-82. 10.1136\/ard.53.3.178","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00753-z","article-title":"Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report","volume":"20","author":"Lin KH","year":"2022","unstructured":"Lin KH, Kao JK. Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report. Pediatr Rheumatol Online J. 2022, 20:92. 10.1186\/s12969-022-00753-z","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070928","article-title":"Clinical and immunological biomarkers for systemic lupus erythematosus","volume":"11","author":"Yu H","year":"2021","unstructured":"Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021, 11:928. 10.3390\/biom11070928","journal-title":"Biomolecules"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02148-8","article-title":"Treatment patterns and clinical characteristics of patients with systemic lupus erythematosus and musculoskeletal symptoms: a retrospective, observational study","volume":"39","author":"Bello N","year":"2022","unstructured":"Bello N, Birt JA, Workman J, Zhou X, Ross-Terres JA, Petri M. Treatment patterns and clinical characteristics of patients with systemic lupus erythematosus and musculoskeletal symptoms: a retrospective, observational study. Adv Ther. 2022, 39:3131-45. 10.1007\/s12325-022-02148-8","journal-title":"Adv Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381871-isolated-myositis-unveiling-systemic-lupus-erythematosus-a-rare-initial-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T03:54:37Z","timestamp":1752897277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381871-isolated-myositis-unveiling-systemic-lupus-erythematosus-a-rare-initial-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.88269","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}